AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13 | +225.0% | 800 | -81.4% | 0.00% | – |
| Q1 2023 | $4 | +33.3% | 4,300 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.7% | 4,300 | +168.8% | 0.00% | – |
| Q3 2022 | $1,000 | -95.8% | 1,600 | -95.9% | 0.00% | -100.0% |
| Q2 2022 | $24,000 | -81.5% | 39,498 | -37.5% | 0.00% | -85.7% |
| Q1 2022 | $130,000 | +364.3% | 63,201 | +1014.9% | 0.01% | +600.0% |
| Q4 2021 | $28,000 | – | 5,669 | +5569.0% | 0.00% | – |
| Q4 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 100 | -98.6% | 0.00% | -100.0% |
| Q2 2020 | $15,000 | -44.4% | 7,300 | -20.7% | 0.00% | -50.0% |
| Q1 2020 | $27,000 | -86.7% | 9,200 | -56.3% | 0.00% | -75.0% |
| Q1 2017 | $203,000 | – | 21,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,498,838 | $22,889,355 | 11.72% |
| Knoll Capital Management, LLC | 500,000 | $4,580,000 | 7.06% |
| GENDELL JEFFREY L | 5,301,914 | $48,565,532 | 4.55% |
| COWEN AND COMPANY, LLC | 3,732,778 | $34,192,246 | 4.02% |
| Tri Locum Partners LP | 1,327,097 | $12,156,209 | 3.70% |
| Samsara BioCapital, LLC | 1,409,409 | $12,910,186 | 2.67% |
| Altium Capital Management LP | 500,000 | $4,580,000 | 2.54% |
| Vivo Capital, LLC | 3,761,438 | $34,454,772 | 2.39% |
| RTW INVESTMENTS, LP | 5,741,939 | $52,596,161 | 1.10% |
| Knott David M Jr | 291,113 | $2,667 | 1.05% |